Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pharmacia & Upjohn describes compounds for amyloidosis

April 10, 1997

NMDA antagonist revealed by Sumitomo

April 10, 1997

Selfadministration device for Imitrex available in the U.S.

April 9, 1997

Agents for cerebral ischemia and neurodegenerative disorders from Boehringer Ingelheim

April 9, 1997

NIH licenses method of reducing aminoglycoside-induced hearing loss

April 9, 1997

Gene Logic/Johns Hopkins collaborate on schizophrenia and depression gene discovery

April 8, 1997

PGE2 agonists/antagonists from Ono

April 8, 1997

Novel antiemetic reported by Dainippon

April 8, 1997

First launch for Zeneca's Zomig

April 7, 1997

Tropisetron prevents vomiting following gynecological surgery

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.